ONCOTHERAPY SOLUTIONS, LLC: Stable, highly potent and safe lead peptide drug conjugate for the treatment of triple-negative breast cancer.
ONCOTHERAPY SOLUTIONS, LLC (Seattle, Washington): Stable, highly potent and safe lead peptide drug conjugate for the treatment of triple-negative breast cancer. Its award of $400,000 is below the median of $407,048 (49th percentile). Dated 49 days ago, it serves as a historical benchmark. Score 55/100. As of 2026-11-04, from NIH RePORTER (newly awarded projects).
Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)
award: $400,000 · 49th percentile of 10,712 NihBiotechGrantPulse records · 1.0x the median
Free preview: all 10 published fields of this record are shown below. Locked: 307 related WA NihBiotechGrantPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Organization | ONCOTHERAPY SOLUTIONS, LLC |
| Location | Seattle, WA |
| Project | Stable, highly potent and safe lead peptide drug conjugate for the treatment of triple-negative breast cancer. |
| Project number | 1R43CA306418-01A1 |
| Mechanism | R43 |
| Institute | National Cancer Institute |
| Award | $400,000 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-17 to 2027-09-14 |
| UEI | SBJCRLLF26A8 |
| award percentile | 49th of 10,712 (median $407,048, 1.0x median) |
| Peer records CSV (308 WA records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch ONCOTHERAPY SOLUTIONS, LLC
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of WA records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock ONCOTHERAPY SOLUTIONS + all 308 WA records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL
- Source agency: NIH RePORTER (newly awarded projects)
- Record date: 2026-09-17
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top NihBiotechGrantPulse records (WA first): ALLEN INSTITUTE · FRED HUTCHINSON CANCER CENTER · UNIVERSITY OF WASHINGTON · UNIVERSITY OF WASHINGTON · UNIVERSITY OF WASHINGTON · Browse all by state and category →
LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Wed, 04 Nov 2026 21:37:56 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: ONCOTHERAPY SOLUTIONS, LLC and 308 Washington peers
- Washington NihBiotechGrantPulse records like this one: 308
- ONCOTHERAPY SOLUTIONS, LLC's award: 49th percentile of 10,712 records
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every Washington peer: $61,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
55 / 100 Lab Budget Score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.
What is the NihBiotechGrantPulse record for ONCOTHERAPY SOLUTIONS, LLC in Seattle, Washington?
ONCOTHERAPY SOLUTIONS, LLC received an NIH award of $400,000 on 2026-09-17: Stable, highly potent and safe lead peptide drug conjugate for the treatment of triple-negative breast cancer..
How does ONCOTHERAPY SOLUTIONS, LLC compare to other Washington NihBiotechGrantPulse records?
Its award of $400,000 is below the median (49th percentile); smaller records often move faster and face less competition. It is 49 days old; check the official source for later updates before acting.
ONCOTHERAPY SOLUTIONS, LLC vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| ONCOTHERAPY SOLUTIONS, LLC | Seattle, WA | 400,000 | 49th | 2026-09-17 |
| KINEA BIO, INC. | Mukilteo, WA | 1,021,458 | 87th | 2026-09-23 |
| UNIVERSITY OF WASHINGTON | SEATTLE, WA | 1,184,018 | 90th | 2026-09-17 |
| UNIVERSITY OF WASHINGTON | SEATTLE, WA | 1,329,606 | 91st | 2026-09-18 |
Related records
NihBiotechGrantPulse: records in Washington NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)
More Washington public-record feeds
Washington L&I Contractor License Pulse in Washington Credit Union Quarterly Changes, Mergers & New Charters (NCUA Call Reports) in Washington Seattle WA Trade Permits Pulse in Washington Nonprofit Revenue, Expenses & Assets from Form 990 in Washington New Executive & Auditor Changes (SEC 8-K) in Washington Washington GHG Reporting Program Publication Pulse in Washington New Trucking Company Registrations in Washington New SEC-Registered Investment Advisers (RIAs) with AUM & Location in Washington
How to monitor ONCOTHERAPY SOLUTIONS, LLC and peer small business sbir/sttr (r41-r44, u43-u44) records
Get new NihBiotechGrantPulse records like ONCOTHERAPY SOLUTIONS, LLC by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get newly funded labs in your territory
NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.